PEMPHIGUS VULGARIS
Clinical trials for PEMPHIGUS VULGARIS explained in plain language.
Never miss a new study
Get alerted when new PEMPHIGUS VULGARIS trials appear
Sign up with your email to follow new studies for PEMPHIGUS VULGARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Dose debate: which rituximab regimen works best for rare blistering disease?
Disease control CompletedThis study looked back at 275 pemphigus patients to see how different doses of rituximab affected disease control and relapse. Pemphigus is a rare autoimmune disease that causes painful blisters on skin and mucous membranes. Researchers tracked outcomes like flare-ups, side effec…
Matched conditions: PEMPHIGUS VULGARIS
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Insulin ointment shows promise for speeding up wound healing in rare blistering disease
Symptom relief CompletedThis study tested whether applying insulin directly to skin sores helps them heal faster in people with pemphigus vulgaris, a rare autoimmune blistering disease. Twenty patients each had three similar sores treated with either long-acting insulin, short-acting insulin, or a saltw…
Matched conditions: PEMPHIGUS VULGARIS
Phase: PHASE2 • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Pemphigus study digs into hidden emotional struggles
Knowledge-focused CompletedThis study looked at 48 adults with pemphigus, a rare blistering skin disease, to understand what makes them feel vulnerable during their illness. Researchers used interviews and questionnaires to explore factors like misdiagnosis, differences in how patients and doctors see dise…
Matched conditions: PEMPHIGUS VULGARIS
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC